Propafenone hydrochloride
Propafenone Hydrochloride is an extended-release oral capsule prescribed to treat certain heart rhythm disorders (arrhythmias). It comes in strengths of 225mg, 325mg, and 425mg, and is manufactured by Strides Pharma as a generic medication. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Propafenone Hydrochloride is an extended-release oral capsule prescribed to treat certain heart rhythm disorders (arrhythmias). It comes in strengths of 225mg, 325mg, and 425mg, and is manufactured by Strides Pharma as a generic medication. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Propafenone hydrochloride", "mediaType": "text/html", "description": " Access the FDA dataset for Propafenone hydrochloride — ANDA 202445 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202445" } ] |
| identifier | ANDA202445 |
| issued | 2016-09-16 |
| keyword |
[ "drug-information", "drug-manufacturers", "drug-safety", "prescription-drugs", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Propafenone hydrochloride |
